查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
體外診斷品管的全球市場 (2022～2030年):成長、未來展望、競爭分析
市場調查報告書
商品編碼
1162489

體外診斷品管的全球市場 (2022～2030年):成長、未來展望、競爭分析

In-Vitro Diagnostics Quality Control Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030
出版日期: | 出版商: Acute Market Reports | 英文 117 Pages | 商品交期: 最快1-2個工作天內

價格

全球體外診斷品管的市場規模，從2022年到2030年的預測期間內預計以3.9％的年複合成長率成長。

感染疾病，心血管障礙，腫瘤檢驗等，對各種疾病的體外診斷檢驗的利用擴大，促進該市場的成長。還有為了探尋個人化醫療和罕見疾病的知識和治療方法著重分子診斷促進體外診斷的使用，也讓該市場成長。

本報告提供全球體外診斷品管的市場調查，市場概要，市場成長的各種影響因素分析，市場規模的變化、預測，各種區分、各地區/主要國家的明細，主要企業簡介等彙整資訊。

目錄

第1章 序文

第2章 摘要整理

第3章 體外診斷品管市場:事業預測、市場動態

  • 世界市場規模:2020年～2030年
  • 市場動態
    • 推動市場要素
    • 阻礙市場要素
    • 主要課題
    • 主要的機會
  • 促進因素、阻礙因素的影響分析
  • See-Saw分析
  • 波特的五力分析
  • PESTEL分析

第4章 體外診斷品管市場:各產品

  • 市場概要
  • 成長、收益分析
  • 市場分類
    • 品管
    • 資料管理解決方案
    • 品質保證服務

第5章 體外診斷品管市場:各用途

  • 市場概要
  • 成長、收益分析
  • 市場分類
    • 免疫化學
    • 臨床化學
    • 血液
    • 凝固
    • 分子診斷
    • 微生物
    • 其他

第6章 北美的體外診斷品管市場

  • 市場概要
  • 體外診斷品管市場:各產品
  • 體外診斷品管市場:各用途
  • 體外診斷品管市場:各地區

第7章 英國及EU的體外診斷品管市場

  • 市場概要
  • 體外診斷品管市場:各產品
  • 體外診斷品管市場:各用途
  • 體外診斷品管市場:各地區

第8章 亞太地區的體外診斷品管市場

  • 市場概要
  • 體外診斷品管市場:各產品
  • 體外診斷品管市場:各用途
  • 體外診斷品管市場:各地區

第9章 南美的體外診斷品管市場

  • 市場概要
  • 體外診斷品管市場:各產品
  • 體外診斷品管市場:各用途
  • 體外診斷品管市場:各地區

第10章 中東、非洲的體外診斷品管市場

  • 市場概要
  • 體外診斷品管市場:各產品
  • 體外診斷品管市場:各用途
  • 體外診斷品管市場:各地區

第11章 企業簡介

  • Abbott Laboratories Inc.
  • Bio-Rad Laboratories, Inc.
  • Helena Laboratories
  • Ortho Clinical Diagnostics, Inc.
  • Randox Laboratories Ltd.
  • Roche Diagnostics
  • Seracare Life Sciences, Inc.
  • Siemens Healthineers
  • Sun Diagnostics, LLC
  • Thermo Fisher Scientific Inc.
  • Sysmex Corporation
  • Quantimetrix Corporation
Product Code: 138465-08-22

Industry Outlook

The global in-vitro diagnostics quality control market expected to grow at compound annual growth rate (CAGR) of 3.9% during the forecast period from 2022 to 2030. In-vitro diagnostics quality control are tests to validate the efficacy and reliability of the in-vitro diagnostic systems and ensure its accuracy and evaluate the impact of environmental conditions and other things that can affect the test results. Erroneous in-vitro diagnostic testing systems have significant side-effects on the patients. Moreover, it can delay in diagnosis and may also result in improper treatment leading to long-term complications and additional healthcare cost. Moreover, failure to identify the pathogen especially during an outbreak can delay in determining the true cause and thereby lead to inaccurate measures for the same. Poor diagnostic quality also leads to poor patient outcomes, increased mortality and morbidity posing a barrier in public health interventions. Growing usage of in-vitro diagnostic testing for various diseases such as infectious diseases, cardiovascular disorders and oncology testing is the major driver for the growth of in-vitro diagnostics quality control market. Moreover, growing inclination towards personalized medicine and molecular diagnostic to explore knowledge and treatment for rare diseases are boosting use of in-vitro diagnostics, thereby growing the market for in-vitro diagnostics quality control market.

Quality Controls Segment Accounted for the Largest Share by Product Type

The in-vitro diagnostics quality control market is segmented in to quality controls, data management solutions, and quality assurance services. In 2021, quality controls segment held the largest share in the market owing to high demand of these products for validating the accuracy and precision of the in-vitro diagnostic tests. Quality control is an important aspect in the clinical and laboratory based testing to ensure safety and accuracy as per standards set by Food and Drug Administration (FDA), European Communities Confederation of Clinical Chemistry and Laboratory Medicine (EC4) and Clinical Laboratory Improvement Amendments (CLIA).

The key players currently engaged in In-vitro diagnostics quality control market include: Siemens Healthineers, Thermo Fisher Scientific, Inc., Roche Diagnostics, Bio-Rad Laboratories, Inc., Abbott Laboratories, Inc., Seracare Life Sciences, Inc., Sysmex Corporation, Helena Laboratories, Sun Diagnostics, LLC among others.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of In-Vitro Diagnostics Quality Control market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the In-Vitro Diagnostics Quality Control market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Product

  • Quality Controls
    • Whole Blood-Based Controls
    • Serum/plasma-based Controls
    • Urine-based controls
    • Others
  • Data Management Solutions
  • Quality Assurance Services

Application

  • Immunochemistry
  • Clinical Chemistry
  • Hematology
  • Coagulation
  • Molecular Diagnostics
  • Microbiology
  • Others

Region Segment (2020-2030; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Global Impact of COVID-19 Segment (2020-2021; US$ Million )

  • Pre COVID-19 situation
  • Post COVID-19 situation

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of In-Vitro Diagnostics Quality Control market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2030.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the In-Vitro Diagnostics Quality Control market?
  • Which is the largest regional market for In-Vitro Diagnostics Quality Control market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving In-Vitro Diagnostics Quality Control market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the In-Vitro Diagnostics Quality Control market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global In-Vitro Diagnostics Quality Control Market
  • 2.2. Global In-Vitro Diagnostics Quality Control Market, By Product, 2021 (US$ Million)
  • 2.3. Global In-Vitro Diagnostics Quality Control Market, By Application, 2021 (US$ Million)
  • 2.4. Global In-Vitro Diagnostics Quality Control Market, By Geography, 2021 (US$ Million)
  • 2.5. Impact of Covid 19
  • 2.6. Attractive Investment Proposition by Geography, 2021
  • 2.7. Competitive Analysis
    • 2.7.1. Market Positioning of Key In-Vitro Diagnostics Quality Control Market Vendors
    • 2.7.2. Strategies Adopted by In-Vitro Diagnostics Quality Control Market Vendors
    • 2.7.3. Key Industry Strategies

3. In-Vitro Diagnostics Quality Control Market: Business Outlook & Market Dynamics

  • 3.1. Introduction
  • 3.2. Global In-Vitro Diagnostics Quality Control Market Value, 2020 - 2030, (US$ Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers
    • 3.3.2. Market Restraints
    • 3.3.3. Key Challenges
    • 3.3.4. Key Opportunities
  • 3.4. Impact Analysis of Drivers and Restraints
  • 3.5. See-Saw Analysis
  • 3.6. Porter's Five Force Model
    • 3.6.1. Supplier Power
    • 3.6.2. Buyer Power
    • 3.6.3. Threat Of Substitutes
    • 3.6.4. Threat Of New Entrants
    • 3.6.5. Competitive Rivalry
  • 3.7. PESTEL Analysis
    • 3.7.1. Political Landscape
    • 3.7.2. Economic Landscape
    • 3.7.3. Technology Landscape
    • 3.7.4. Legal Landscape
    • 3.7.5. Social Landscape

4. In-Vitro Diagnostics Quality Control Market: By Product, 2020-2030, USD (Million)

  • 4.1. Market Overview
  • 4.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 4.3. Market Segmentation
    • 4.3.1. Quality Controls
      • 4.3.1.1. Whole Blood-Based Controls
      • 4.3.1.2. Serum/plasma-based Controls
      • 4.3.1.3. Urine-based controls
      • 4.3.1.4. Others
    • 4.3.2. Data Management Solutions
    • 4.3.3. Quality Assurance Services

5. In-Vitro Diagnostics Quality Control Market: By Application, 2020-2030, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 5.3. Market Segmentation
    • 5.3.1. Immunochemistry
    • 5.3.2. Clinical Chemistry
    • 5.3.3. Hematology
    • 5.3.4. Coagulation
    • 5.3.5. Molecular Diagnostics
    • 5.3.6. Microbiology
    • 5.3.7. Others

6. North America In-Vitro Diagnostics Quality Control Market, 2020-2030, USD (Million)

  • 6.1. Market Overview
  • 6.2. In-Vitro Diagnostics Quality Control Market: By Product, 2020-2030, USD (Million)
  • 6.3. In-Vitro Diagnostics Quality Control Market: By Application, 2020-2030, USD (Million)
  • 6.4.In-Vitro Diagnostics Quality Control Market: By Region, 2020-2030, USD (Million)
    • 6.4.1.North America
      • 6.4.1.1. U.S.
      • 6.4.1.2. Canada
      • 6.4.1.3. Rest of North America

7. UK and European Union In-Vitro Diagnostics Quality Control Market, 2020-2030, USD (Million)

  • 7.1. Market Overview
  • 7.2. In-Vitro Diagnostics Quality Control Market: By Product, 2020-2030, USD (Million)
  • 7.3. In-Vitro Diagnostics Quality Control Market: By Application, 2020-2030, USD (Million)
  • 7.4.In-Vitro Diagnostics Quality Control Market: By Region, 2020-2030, USD (Million)
    • 7.4.1.UK and European Union
      • 7.4.1.1. UK
      • 7.4.1.2. Germany
      • 7.4.1.3. Spain
      • 7.4.1.4. Italy
      • 7.4.1.5. France
      • 7.4.1.6. Rest of Europe

8. Asia Pacific In-Vitro Diagnostics Quality Control Market, 2020-2030, USD (Million)

  • 8.1. Market Overview
  • 8.2. In-Vitro Diagnostics Quality Control Market: By Product, 2020-2030, USD (Million)
  • 8.3. In-Vitro Diagnostics Quality Control Market: By Application, 2020-2030, USD (Million)
  • 8.4.In-Vitro Diagnostics Quality Control Market: By Region, 2020-2030, USD (Million)
    • 8.4.1.Asia Pacific
      • 8.4.1.1. China
      • 8.4.1.2. Japan
      • 8.4.1.3. India
      • 8.4.1.4. Australia
      • 8.4.1.5. South Korea
      • 8.4.1.6. Rest of Asia Pacific

9. Latin America In-Vitro Diagnostics Quality Control Market, 2020-2030, USD (Million)

  • 9.1. Market Overview
  • 9.2. In-Vitro Diagnostics Quality Control Market: By Product, 2020-2030, USD (Million)
  • 9.3. In-Vitro Diagnostics Quality Control Market: By Application, 2020-2030, USD (Million)
  • 9.4.In-Vitro Diagnostics Quality Control Market: By Region, 2020-2030, USD (Million)
    • 9.4.1.Latin America
      • 9.4.1.1. Brazil
      • 9.4.1.2. Mexico
      • 9.4.1.3. Rest of Latin America

10. Middle East and Africa In-Vitro Diagnostics Quality Control Market, 2020-2030, USD (Million)

  • 10.1. Market Overview
  • 10.2. In-Vitro Diagnostics Quality Control Market: By Product, 2020-2030, USD (Million)
  • 10.3. In-Vitro Diagnostics Quality Control Market: By Application, 2020-2030, USD (Million)
  • 10.4.In-Vitro Diagnostics Quality Control Market: By Region, 2020-2030, USD (Million)
    • 10.4.1.Middle East and Africa
      • 10.4.1.1. GCC
      • 10.4.1.2. Africa
      • 10.4.1.3. Rest of Middle East and Africa

11. Company Profile

  • 11.1. Abbott Laboratories Inc.
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Portfolio
    • 11.1.4. Strategic Initiatives
  • 11.2. Bio-Rad Laboratories, Inc.
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Portfolio
    • 11.2.4. Strategic Initiatives
  • 11.3. Helena Laboratories
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Portfolio
    • 11.3.4. Strategic Initiatives
  • 11.4. Ortho Clinical Diagnostics, Inc.
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Portfolio
    • 11.4.4. Strategic Initiatives
  • 11.5. Randox Laboratories Ltd.
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Portfolio
    • 11.5.4. Strategic Initiatives
  • 11.6. Roche Diagnostics
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Portfolio
    • 11.6.4. Strategic Initiatives
  • 11.7. Seracare Life Sciences, Inc.
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Portfolio
    • 11.7.4. Strategic Initiatives
  • 11.8. Siemens Healthineers
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Portfolio
    • 11.8.4. Strategic Initiatives
  • 11.9. Sun Diagnostics, LLC
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Portfolio
    • 11.9.4. Strategic Initiatives
  • 11.10. Thermo Fisher Scientific Inc.
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Portfolio
    • 11.10.4. Strategic Initiatives
  • 11.11. Sysmex Corporation
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Portfolio
    • 11.11.4. Strategic Initiatives
  • 11.12. Quantimetrix Corporation
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Portfolio
    • 11.12.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global In-Vitro Diagnostics Quality Control Market By Product, 2020-2030, USD (Million)
  • TABLE 2 Global In-Vitro Diagnostics Quality Control Market By Quality Controls, 2020-2030, USD (Million)
  • TABLE 3 Global In-Vitro Diagnostics Quality Control Market By Application, 2020-2030, USD (Million)
  • TABLE 4 North America In-Vitro Diagnostics Quality Control Market By Product, 2020-2030, USD (Million)
  • TABLE 5 North America In-Vitro Diagnostics Quality Control Market By Quality Controls, 2020-2030, USD (Million)
  • TABLE 6 North America In-Vitro Diagnostics Quality Control Market By Application, 2020-2030, USD (Million)
  • TABLE 7 UK and European Union In-Vitro Diagnostics Quality Control Market By Product, 2020-2030, USD (Million)
  • TABLE 8 UK and European Union In-Vitro Diagnostics Quality Control Market By Quality Controls, 2020-2030, USD (Million)
  • TABLE 9 UK and European Union In-Vitro Diagnostics Quality Control Market By Application, 2020-2030, USD (Million)
  • TABLE 10 Asia Pacific In-Vitro Diagnostics Quality Control Market By Product, 2020-2030, USD (Million)
  • TABLE 11 Asia Pacific In-Vitro Diagnostics Quality Control Market By Quality Controls, 2020-2030, USD (Million)
  • TABLE 12 Asia Pacific In-Vitro Diagnostics Quality Control Market By Application, 2020-2030, USD (Million)
  • TABLE 13 Latin America In-Vitro Diagnostics Quality Control Market By Product, 2020-2030, USD (Million)
  • TABLE 14 Latin America In-Vitro Diagnostics Quality Control Market By Quality Controls, 2020-2030, USD (Million)
  • TABLE 15 Latin America In-Vitro Diagnostics Quality Control Market By Application, 2020-2030, USD (Million)
  • TABLE 16 Middle East and Africa In-Vitro Diagnostics Quality Control Market By Product, 2020-2030, USD (Million)
  • TABLE 17 Middle East and Africa In-Vitro Diagnostics Quality Control Market By Quality Controls, 2020-2030, USD (Million)
  • TABLE 18 Middle East and Africa In-Vitro Diagnostics Quality Control Market By Application, 2020-2030, USD (Million)

List of Figures

  • FIG. 1 Global In-Vitro Diagnostics Quality Control Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global In-Vitro Diagnostics Quality Control Market: Quality Assurance
  • FIG. 5 Global In-Vitro Diagnostics Quality Control Market, By Product, 2021
  • FIG. 6 Global In-Vitro Diagnostics Quality Control Market, By Application, 2021
  • FIG. 7 Global In-Vitro Diagnostics Quality Control Market, By Geography, 2021
  • FIG. 8 Global In-Vitro Diagnostics Quality Control Market, By Product, 2021 Vs 2030, %
  • FIG. 9 Global In-Vitro Diagnostics Quality Control Market, By Application, 2021 Vs 2030, %
  • FIG. 10 U.S. In-Vitro Diagnostics Quality Control Market (US$ Million), 2020 - 2030
  • FIG. 11 Canada In-Vitro Diagnostics Quality Control Market (US$ Million), 2020 - 2030
  • FIG. 12 Rest of North America In-Vitro Diagnostics Quality Control Market (US$ Million), 2020 - 2030
  • FIG. 13 UK In-Vitro Diagnostics Quality Control Market (US$ Million), 2020 - 2030
  • FIG. 14 Germany In-Vitro Diagnostics Quality Control Market (US$ Million), 2020 - 2030
  • FIG. 15 Spain In-Vitro Diagnostics Quality Control Market (US$ Million), 2020 - 2030
  • FIG. 16 Italy In-Vitro Diagnostics Quality Control Market (US$ Million), 2020 - 2030
  • FIG. 17 France In-Vitro Diagnostics Quality Control Market (US$ Million), 2020 - 2030
  • FIG. 18 Rest of Europe In-Vitro Diagnostics Quality Control Market (US$ Million), 2020 - 2030
  • FIG. 19 China In-Vitro Diagnostics Quality Control Market (US$ Million), 2020 - 2030
  • FIG. 20 Japan In-Vitro Diagnostics Quality Control Market (US$ Million), 2020 - 2030
  • FIG. 21 India In-Vitro Diagnostics Quality Control Market (US$ Million), 2020 - 2030
  • FIG. 22 Australia In-Vitro Diagnostics Quality Control Market (US$ Million), 2020 - 2030
  • FIG. 23 South Korea In-Vitro Diagnostics Quality Control Market (US$ Million), 2020 - 2030
  • FIG. 24 Rest of Asia In-Vitro Diagnostics Quality Control Market (US$ Million), 2020 - 2030
  • FIG. 25 Brazil In-Vitro Diagnostics Quality Control Market (US$ Million), 2020 - 2030
  • FIG. 26 Mexico In-Vitro Diagnostics Quality Control Market (US$ Million), 2020 - 2030
  • FIG. 27 Rest of Latin America In-Vitro Diagnostics Quality Control Market (US$ Million), 2020 - 2030
  • FIG. 28 GCC In-Vitro Diagnostics Quality Control Market (US$ Million), 2020 - 2030
  • FIG. 29 Africa In-Vitro Diagnostics Quality Control Market (US$ Million), 2020 - 2030
  • FIG. 30 Rest of Middle East and Africa In-Vitro Diagnostics Quality Control Market (US$ Million), 2020 - 2030